14 -5 (37) 2021 — Yuldashev B.S. — FEATURES OF THE PROBLEM OF BREAST CANCER BY REGION. (LITERATURE REVIEW)

FEATURES OF THE PROBLEM OF BREAST CANCER BY REGION. (LITERATURE REVIEW)

Yuldashev B.S. Urgency Branch Tashkent Medical Academy

Resume

In recent years, breast cancer among women has increased and remains a disease with a very high lethal risk. If the cancer is detected and treated early,  chance of survival increases in patients with breast cancer. According to the WHO, in 2020, breast cancer accounted for every eighth new case of cancer in the world and every fourth among women: this disease was diagnosed in 2.3 million people, 685 thousand died from it. In recent years, a number of studies have been carried out indicating the presence of specific features of the breast cancer problem in the Central Asian and Caucasian regions. In the structure of mortality of the female population of Uzbekistan from malignant neoplasms, malignant tumors of the mammary gland have the largest specific weight (20.4%).

Key words: Breast cancer, relapses, mortality, benign, malignant.

First page

51

Last page

54

For citation: Yuldashev B.S. FEATURES OF THE PROBLEM OF BREAST CANCER BY REGION. (LITERATURE REVIEW) //New Day in Medicine 5(37)2021 51-54 https://cutt.ly/0TE1I5u

LIST OF REFERENCES:

  1. Aleksandrova L.M., Starinskiy V.V., Kaprin A.D. s soavt. Profilaktika onkologicheskikh zabolevaniy kak osnova vzaimodeystviya onkologicheskoy sluzhby s pervichnym zvenom zdravookhraneniya //Issledovaniya i praktika v meditsine. – 2017. – T. 4, № 1. – S. 74-80.
  2. Semiglazov V.F. Rak molochnoy zhelezy: mul’tidistsiplinarnyy podkhod k lecheniyu. //Prakticheskaya onkologiya 2015;16(2):49-52.
  3. Semiglazov V.F., Merabishvili B.M., Semiglazov V.V. s soavt. Epidemiologiya i skrining raka molochnoy zhelezy //Voprosy onkologii. – 2017. -T. 63, № 3. – S. 375-384.
  4. Llanos A.A., Chandwani S., Bandera E.V., Hirshfield K.M., Lin Y., Ambrosone C.B., et al. Associations between sociodemographic and clinicopathological factors and breast cancer subtypes in a population-based study. //Cancer Causes Control. (2015) 26:1737–50. doi: 10.1007/s10552-015-0667-4
  5. Ademuyiwa F.O., Tao Y., Luo J., Weilbaecher K., Ma C.X. Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians. //Breast Cancer Res Treat. (2017) 161:491–9. doi: 10.1007/s10549-016-4062-y
  6. Williams D.R., Mohammed S.A., Shields A.E.. Understanding and effectively addressing breast cancer in African American women: Unpacking the social context. //Cancer. (2016) 122:2138–49. doi: 10.1002/cncr.29935
  7. Iqbal J., Ginsburg O., Rochon P.A., Sun P, Narod S.A. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. (2015) 313:165–73. doi: 10.1001/jama.2014.17322
  8. Tao L., Gomez S.L., Keegan T.H., Kurian A.W., Clarke C.A. Breast cancer mortality in african-american and non-hispanic white women by molecular subtype and stage at diagnosis: a population-based study. //Cancer Epidemiol Biomarkers Prev. (2015) 24:1039–45. doi: 10.1158/1055-9965.EPI-15-0243
  9. Bae S.Y., Jung S.P., Lee S.K., et al. Prognostic value of immunohistochemically detected p53 in adjuvant chemotherapy- treated triple negative breast cancer. //Kaohsiung J Med Sci 2018; 34:663–72.
  10. Hossain F., Danos D., Prakash O., Gilliland A., Ferguson T.F., Simonsen N., et al. Neighborhood social determinants of triple negative breast cancer. //Front Public Health. (2019) 7:18. doi: 10.3389/fpubh.2019.00018
  11. Bandera EV, Chandran U, Hong CC, Troester MA, Bethea TN, Adams-Campbell LL, et al. Obesity, body fat distribution, and risk of breast cancer subtypes in African American women participating in the AMBER consortium. //Breast Cancer Res Treat. (2015) 150:655–66. doi: 10.1007/s10549-015-3353-z
  12. Yedjou C.G., Sims J.N., Miele L.et al. Health and Racial Disparity in Breast Cancer. Advances in experimental medicine and biology. 2019;  [PubMed PMID: 31456178]
  13. Flegal K.M., Kruszon-Moran D., Carroll M.D., Fryar C.D., Ogden C.L. Trends in obesity among adults in the United States, 2005 to 2014. //JAMA. (2016) 315:2284–91. doi: 10.1001/jama.2016.6458
  14. Kohler B.A., Sherman R.L., Howlader N.. at al. Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State. //L.J Nat’l Cancer Inst. 2015 Mar 30; 107(6):djv048. doi: 10.1093/jnci/djv048. Print 2015 Jun.PMID: 25825511
  15. Chichua N.A., Talayeva SH.ZH., Omarbayeva N.A., Smagulova G.K. Osobennosti techeniya troynogo negativnogo raka molochnoy zhelezy. Onkol. i radiol. Kazakhstana. 2015; (3): 26–31.
  16. Khmel’nitskaya N.M. Morfologiya raka molochnoy zhelezy u zhenshchin Respubliki Tadzhikistan n slavyanskoy etnicheskoy gruppy /N.M. Khmel’nitskaya, F.YU. Meliyeva //Meditsinskiy al’manakh. – Nizhniy Novgorod, 2011, №5. – S. 127-129.
  17. Umarova S.G., Zikiryakhodzhayev A.D., Zikiryakhodzhayev D.Z. Epidemiologicheskiye aspekty zlokachestvennykh novoobrazovaniy organov reproduktivnoy sistemy u zhenshchin v Tadzhikistane. – Dushanbe: //Optima, 2013. -120 s.
  18. Марданлы Ф.А., Алиева Ф.К., Джафарова Е.Р. и др. Динамика заболеваемости злокачественными новообразованиями в Азербайджанской Республике за период с января по апрель 2014 года. //Azərbaycan təbabətinin müasir nailiyyətləri. 2015; (1): 148–154.
  19. Vatankha S.S. Epidemiologicheskiye aspekty zabolevayemosti rakom molochnoy zhelezy v gorode Baku //Kazanskiy meditsinskiy zhurnal, 2018 g., tom 99, №2. – S.  287-290.
  20. Khudaykulov T.K., Khudaykulov A.T. Zabolevayemost’ rakom molochnoy zhelezy v Uzbekistane //Povolzhskiy onkologicheskiy vestnik. – 2016. – №2. – S. 38-42.

file

download